Opening remark in VacChina 2011 International Conference held at Shanghai, 29-30 Nov 2011.

1. Dr. Priyabrata Pattnaik
Biomanufacturing Sciences Network
Merck Millipore

2. Vaccines is the most cost effective
health-care intervention available

3. - Each vaccine process is unique
- Scope for high degree of innovation

4. Worldwide Vaccines market
is growing at 8% CAGR

5. And…. there is
Unmet demand in developing countries

6. ….things are changing……
Emerging markets are evolving faster
Vaccine manufacturers expanding their
capabilities to address need of emerging market

7. • Need to increase the immunization
coverage rates for both pediatric and
adolescents / adults vaccines
• Huge demand for traditional/ classical
vaccines, low cost but high volume
demand

8. Growth in emerging countries can happen by
- Building production capacity
- Matching global quality standards

9. The challenge…..
• Vaccine manufacturing is
- critical and complex
- requires capital-intensive capabilities
- high GMP standards

10. Increasing understanding of
- Product
- Process
- Quality standards
- Clinical impact

11. Assessing Risk and
Managing Risk

12. Striking the balance between
- Innovation
- Speed
- Quality

13. Bottom line…..
Vaccine awareness is key to success.

14. Thank You